CytoDyn (CYDY) Interest Coverage Ratio Growth (5y) (2017 - 2026)
Powered by 
Analysis
CytoDyn (CYDY) Interest Coverage Ratio Growth (5y) (2017 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.77 Bn | 130.92 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.51 Bn | 77.52 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.51 Bn | 58.32 Bn | 1.37 Bn |
| 4 | Moderna | 58.20 Bn | 53.06 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.04 Bn | 44.04 Bn | - |
| 6 | BeOne Medicines | 39.99 Bn | 34.89 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.45 Bn | 32.14 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.40 Bn | 27.56 Bn | - |
| 9 | Insmed | 27.44 Bn | 26.28 Bn | 358.27 Mn |
| 10 | CytoDyn | 257.86 Mn | 257.86 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| May 31, 2026 | -81.99% |
| Feb 28, 2026 | -17.78% |
| Nov 30, 2025 | -79.28% |
| Aug 31, 2025 | -8.53% |
| May 31, 2025 | -55.00% |
| Feb 28, 2025 | -12.31% |
| Nov 30, 2024 | 4.96% |
| Aug 31, 2024 | 52.83% |
| May 31, 2024 | -15.42% |
| Feb 29, 2024 | 24.70% |
| Nov 30, 2023 | 20.31% |
| Aug 31, 2023 | 44.86% |
| May 31, 2023 | 61.07% |
| Feb 28, 2023 | 38.64% |
| Nov 30, 2022 | 8.34% |
| Aug 31, 2022 | 33.70% |
| May 31, 2022 | -14.87% |
| Feb 28, 2022 | 61.92% |
| Nov 30, 2021 | 7.95% |
| Aug 31, 2021 | 17.08% |